As of 2025-05-17, the EV/EBITDA ratio of Rich Pharmaceuticals Inc (RCHA) is -1.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RCHA's latest enterprise value is 2.29 mil USD. RCHA's TTM EBITDA according to its financial statements is -1.88 mil USD. Dividing these 2 quantities gives us the above RCHA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 12.7x | 10.6x |
| Forward P/E multiples | 4.6x - 6.9x | 5.8x |
| Fair Price | (0.02) - (0.01) | (0.02) |
| Upside | -3233.6% - -2706.6% | -3131.9% |
| Date | EV/EBITDA |